Universal Ibogaine (FRA:JC4) Debt-to-Asset : 0.52 (As of Apr. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Universal Ibogaine Debt-to-Asset?

Universal Ibogaine's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2024 was €0.09 Mil. Universal Ibogaine's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Apr. 2024 was €1.80 Mil. Universal Ibogaine's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Apr. 2024 was €3.63 Mil. Universal Ibogaine's debt to asset for the quarter that ended in Apr. 2024 was 0.52.

Universal Ibogaine Debt-to-Asset Historical Data

The historical data trend for Universal Ibogaine's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Debt-to-Asset Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Debt-to-Asset

Get a 7-Day Free Trial

0.03

0.28

0.51

Universal Ibogaine Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24
Debt-to-Asset	Get a 7-Day Free Trial															0.45	0.51	0.51	0.50	0.52

Competitive Comparison of Universal Ibogaine's Debt-to-Asset

For the Biotechnology subindustry, Universal Ibogaine's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Debt-to-Asset falls into.

Universal Ibogaine Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Universal Ibogaine's Debt-to-Asset for the fiscal year that ended in Jul. 2023 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.242	+	0.658)	/	3.765
	=	0.50

Universal Ibogaine's Debt-to-Asset for the quarter that ended in Apr. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.091	+	1.797)	/	3.625
	=	0.52

Universal Ibogaine (FRA:JC4) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Universal Ibogaine Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (FRA:JC4) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

IBOGF:USA IBO:Canada

Address

815 8th Avenue South West, Suite 600, Calgary, AB, CAN, T2P 3P2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Universal Ibogaine Headlines

No Headlines